Zhu Jun

Professional Biography

Dr. Zhu Jun is Chief Physician in Lymphoma at Peking University Cancer Hospital, Beijing. Zhu serves as Director, Department of Lymphoma Oncology. Clinical expertise includes Diffuse large B-cell lymphoma (DLBCL) — including MYC/BCL2 double-expressor subtypes, Hodgkin lymphoma — risk-adapted chemoimmunotherapy, Extranodal NK/T-cell lymphoma — asparaginase-based regimens; NCCN-cited data, Peripheral T-cell lymphoma — JAK1 inhibitor (golidocitinib) and novel combination regimens. Built China's first specialized lymphoma diagnosis-and-treatment center and the country's largest lymphoma-focused autologous HSCT program at Peking University Cancer Hospital — raised the institutional 5-year lymphoma survival from the national baseline of 32.6% to 62% (10-year survival to 52%) over 25 years. 200+ papers as corresponding author in journals including Nature Medicine, The Lancet Oncology, JAMA, Blood, and Annals of Oncology; 5 co-authored specialized monographs.